e-learning
resources
Berlin 2008
Tuesday, 07.10.2008
Metabolic syndrome and systemic inflammation in obstructive sleep apnoea
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Procoagulant and anticoagulant factors in patients with sleep apnea
T. Takagi, E. Gabazza, A. Fujiwara, H. Nakahara, H. Fujimoto, A. Yamaguchi, H. Yasui, T. Kobayashi, H. Kobayashi, C. D‘Alessandro-Gabazza, Y. Takei, O. Taguchi (Tsu/Mie, Japan)
Source:
Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea
Session:
Metabolic syndrome and systemic inflammation in obstructive sleep apnoea
Session type:
E-Communication Session
Number:
3231
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Takagi, E. Gabazza, A. Fujiwara, H. Nakahara, H. Fujimoto, A. Yamaguchi, H. Yasui, T. Kobayashi, H. Kobayashi, C. D‘Alessandro-Gabazza, Y. Takei, O. Taguchi (Tsu/Mie, Japan). Procoagulant and anticoagulant factors in patients with sleep apnea. Eur Respir J 2008; 32: Suppl. 52, 3231
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on acute decompensated pulmonary hypertension
Adherence predictors to positive airway pressure (PAP) treatment in patients with obstructive sleep apnea (OSA)
The search for realistic evidence on the outcomes of obstructive sleep apnoea
Related content which might interest you:
Day–night variations in endothelial dysfunction markers and haemostatic factors in sleep apnoea
Source: Eur Respir J 2012; 39: 913-918
Year: 2012
Investigation of various factors in obstructive sleep apnea syndrome patients
Source: Eur Respir J 2006; 28: Suppl. 50, 194s
Year: 2006
Sleep apnoea as a risk factor for stroke
Source: 5th Sleep and Breathing Conference
Year: 2019
Impact of antihypertensive drugs on Watch-PAT variables in patients with obstructive sleep apnea.
Source: International Congress 2019 – Diagnostic issues in obstructive sleep apnoea
Year: 2019
Circulating cell-derived microparticles in patients with minimally symptomatic obstructive sleep apnoea
Source: Eur Respir J 2009; 33: 574-580
Year: 2009
Serum fibrinogen in patients with obstructive sleep apnea
Source: Virtual Congress 2020 – Consequences for obstructive sleep apnoea and potential modalities for early identification
Year: 2020
Circadian rythm of circulating microparticles in patients with obstructive sleep apnea
Source: Annual Congress 2011 - Phenotyping and monitoring of airway diseases
Year: 2011
The effects of opioids on perioperative outcomes in patients with obstructive sleep apnoea
Source: International Congress 2016 – Comorbid sleep apnoea in specific clinical entities and differential diagnosis of sleep disorders
Year: 2016
Metabolic syndrome in obstructive sleep apnoea patients
Source: Annual Congress 2007 - Sleep apnoea
Year: 2007
Menopause and cardiovascular risk factors in sleep apnea
Source: Eur Respir J 2006; 28: Suppl. 50, 200s
Year: 2006
Prevalence of complex sleep apnea among German patients with obstructive sleep apnea
Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea
Year: 2009
Sleep apnea as a cause of sleep misperception in elderly insomnia patients
Source: International Congress 2017 – Phenotyping obstructive sleep apnoea
Year: 2017
The use of beta-blockers is not associated with increased daytime sleepiness in patients with obstructive sleep apnoea
Source: International Congress 2019 – Beyond continuous positive airway pressure treatment
Year: 2019
Cardiovascular risk factors and the metabolic syndrome in patients with obstructive sleep apnea
Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea
Year: 2008
Unrecognised systemic hypertension in patients with obstructive sleep apnoea
Source: Eur Respir J 2006; 28: Suppl. 50, 643s
Year: 2006
Return of sleep apnoea and sleep fragmentation following CPAP withdrawal in patients with obstructive sleep apnoea
Source: Eur Respir J, 53 (5) 1802351; 10.1183/13993003.02351-2018
Year: 2019
Nocturnal intermitent hypoxemia in patients with pulmonary hypertension and sleep apnea hypopnea syndrome
Source: Eur Respir J 2006; 28: Suppl. 50, 657s
Year: 2006
Prolonged symptoms and sleep quality after hospitalization for covid-19 in patients with obstructive sleep apnoea
Source: Virtual Congress 2021 – Different treatment modalities and impact of comorbidities on sleep disordered breathing
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept